Marathon Patent Group, Inc. (MARA) - NASDAQ
  • Wed, Jan. 6, 12:45 PM
    | Wed, Jan. 6, 12:45 PM | 1 Comment
  • Nov. 17, 2015, 12:47 PM
    | Nov. 17, 2015, 12:47 PM | 8 Comments
  • Oct. 2, 2015, 9:54 AM
    • An Eastern Michigan federal court has denied a joint motion by Ford and Fiat Chrysler to stay all proceedings for Marathon Patent's (NASDAQ:MARA) infringement suits against the companies pending patent reexamination and inter partes reviews.
    • The cases were moved to Michigan from California's Central District (CDCA) in May. Trials for 8 cases still in CDCA are expected to commence on March 15, 2016.
    • Two months ago: Marathon merging with Luxembourg's Uniloc
    | Oct. 2, 2015, 9:54 AM
  • Jul. 2, 2015, 12:04 PM
    • In a preliminary opinion, a Munich court has ruled Joline GmbH, Signus Medizintechnik GmbH and PanMedical infringe Marathon's (MARA +2.8%) '260 European patent.
    • The decision follows a June 19 ruling upholding the validity of the patent's claims, following a challenge by Stryker. Marathon says it's seeking "an equitable licensing agreement, much like the one just executed with Maxxspine Limited, which involves a lump sum royalty payment for products already sold, as well as a running royalty rate for future sales."
    • Shares are up moderately. They tumbled last month after a Delaware jury ruled against Marathon partner Bridgestone in an infringement suit.
    | Jul. 2, 2015, 12:04 PM
  • Jun. 12, 2015, 12:45 PM
    | Jun. 12, 2015, 12:45 PM
  • Jun. 11, 2015, 12:29 PM
    • A Delaware jury has ruled against tire maker Bridgestone in its infringement suit against Schrader-Bridgeport International. Marathon (NASDAQ:MARA) had "advised [Bridgestone] and provided substantially all of the financing of this litigation," and owns "contract rights to the revenue associated with the outcome of this case."
    • Marathon CEO Doug Croxall: "We are clearly disappointed by the jury's ruling. It is a decision Bridgestone will promptly appeal as we believe the jury erred in their verdict. This outcome has no bearing on our German case and we remain confident in the validity and infringement of our European patent ... Marathon has invested in a diversified portfolio consisting of 413 patents across 19 different subsidiaries, 12 of which are in active litigation with approximately 50 defendants."
    • Shares had plunged on the verdict before Marathon put out a PR. They remain at their lowest levels since 2013.
    | Jun. 11, 2015, 12:29 PM
  • Jun. 11, 2015, 11:06 AM
    • Marathon Patent (NASDAQ:MARA) has cratered on volume of 1.54M shares, far above a 3-month daily average of 105K.
    • No news has hit the wires yet, but drops of this magnitude for IP licensing firms are typically due to legal setbacks ... of which there have been many for the group over the last year.
    • Update: A jury ruling in an infringement suit by Marathon partner Bridgestone was the culprit.
    | Jun. 11, 2015, 11:06 AM
  • Jun. 9, 2015, 4:04 PM
    • Marathon Patent's (NASDAQ:MARA) MedTech Development and Orthophoenix  subsidiaries have entered into a license agreement. The licensee's name is undisclosed due to a confidentiality agreement.
    • The deal is said to cover "the German parts of European patent EP 1 938 765 B1 and EP 1 104 260 B2, both of which have been asserted in Germany and relate to medical devices involved in kyphoplasty surgery." Marathon adds Orthophoenix's patent portfolio covers IP related to bone-treatment techniques.
    • Marathon rallied today on volume of 520K shares; the 3-month daily average is 95K. Licensing deals with Thomson Reuters and Nordstrom were announced last week.
    | Jun. 9, 2015, 4:04 PM
  • Apr. 10, 2015, 2:10 PM
    • Under pressure for much of 2015, Marathon Patent Group (NASDAQ:MARA) has jumped higher today on volume of 169K shares (above a 3-month daily average of 102K). Shares remain down 31% YTD.
    • Yesterday, Marathon announced it's suing Yahoo in Germany for allegedly infringing the German part of a European patent via Flickr. On Tuesday, the company announced a settlement/licensing deal with medical device maker Varian Medical.
    | Apr. 10, 2015, 2:10 PM
  • Mar. 30, 2015, 3:13 PM
    • Today's notable tech gainers include industrial laser maker IPG Photonics (IPGP +4.3%), cloud classroom software provider 2U (TWOU +5.8%), California solar installer Solar3D (SLTD +10.3%), Korean analog/mixed-signal chipmaker MagnaChip (MX +6.8%), privileged account security software vendor CyberArk (CYBR +5.3%), haptic tech provider Immersion (IMMR +4.6%), and solar power optimizer maker/recent IPO SolarEdge (SEDG +4.8%). The Nasdaq is up 1.1%.
    • There are relatively few major decliners. The group includes Chinese online video platform Youku (YOKU -4.5%), Chinese solar cell/module maker Yingli (YGE -5.6%), authentication hardware/software provider Vasco (VDSI -3%), and IP licensing firm Marathon Patent Group (MARA -8.8%).
    • Solar3D is now up 97% from a March 18 close of $2.57. SolarEdge is up 23% from last week's $18 IPO price. Immersion might be getting a lift from a Barclays report stating Analog Devices will be supplying converter ICs to help enable haptics support on future iPhones/iPads.
    • Youku has fallen to fresh 52-week lows, and is now down 18% since posting Q4 results and disclosing an SEC inquiry on March 19. Marathon is down 11% since reporting last Thursday.
    • Previously covered: BlackBerry, Altera, Ambarella, OTI, Angie's List, You On Demand,, Chinese online real estate
    | Mar. 30, 2015, 3:13 PM
  • Mar. 26, 2015, 4:10 PM
    • Marathon Patent (NASDAQ:MARA): FY'14 EPS of $0.36 vs. -$0.03 in FY'13
    • Revenue of $21.4M (+526% Y/Y)
    • Shares +4.5%.
    | Mar. 26, 2015, 4:10 PM
  • Feb. 3, 2015, 9:10 AM
    • Spherix's (NASDAQ:SPEX) board has rejected a proposal from fellow IP licensing firm Marathon Patent Group (NASDAQ:MARA) "indicating Marathon's interest in acquiring Spherix in a stock-for-stock transaction valuing Spherix at a 15% premium above the recent market price of Spherix's common stock."
    • Spherix CEO Anthony Hayes: "After careful review and consideration, our Board of Directors has unanimously determined that Marathon's unsolicited proposal substantially undervalues Spherix and does not reflect the value of the Company's patent portfolio and its current business."
    • SPEX +9.7% to $1.02 in premarket trading; the company currently sports a $28M market cap. Marathon has a $98M market cap; its shares are unchanged premarket.
    | Feb. 3, 2015, 9:10 AM | 1 Comment
  • Nov. 20, 2014, 1:51 PM
    • Marathon Patent Group (MARA -4%) has filed to sell 499K shares - 370K related to convertible notes, 129K related to warrants - on behalf of existing holders. (prospectus)
    • Marathon had 8M shares outstanding as of Q3.
    | Nov. 20, 2014, 1:51 PM | 3 Comments
  • Oct. 6, 2014, 1:59 PM
    • In a brief 8-K, Marathon Patent Group (MARA +2.2%) states it "executed settlement agreements that have generated approximately $13.5 million in aggregate revenue to the Company" during Q3.
    • Separately, boutique i-bank Midtown Partners has launched coverage on Marathon with a Strong Buy rating.
    | Oct. 6, 2014, 1:59 PM
  • Aug. 15, 2014, 12:39 PM
    • Worlds (OTCQB:WDDD -15.3%), Spherix (SPEX -5.8%) and Marathon Patent Group (MARA -3.6%) have sold off after a federal appeals court ruled against Vringo in its IP suit against Google, arguing the patent claims it has asserted are invalid due to obviousness.
    • Notably, the court referenced a recent Supreme Court ruling that upheld the patentability of software concepts that advance or improve upon existing ideas, but also declared mere abstract software ideas on a computer can't be patented.
    • Spherix is still well above where it traded before an AT&T settlement was disclosed on Monday.
    | Aug. 15, 2014, 12:39 PM | 5 Comments
  • Jun. 19, 2014, 1:15 PM
    • In a closely-watched case, the Supreme Court has upheld the patentability of software concepts, albeit while setting limits: Companies can't patent a mere abstract idea on a computer, but can patent software ideas that advance or improve upon existing ideas.
    • The ruling comes a month after Sen. Pat Leahy shelved a hotly-contested bill aimed at limiting the power of patent trolls. Many tech giants and startups backed the bill, while IP licensing firms staunchly opposed it.
    • A few licensing firms are trading lower on a moderately down day for tech: VRNG -2.2%. ACTG -1.3%. VHC -2.8%. PRKR -3.8%. SPEX -3.1%.
    • Other related names: RPXC, WILN, DSS, CRDS, MARA.
    | Jun. 19, 2014, 1:15 PM | 10 Comments
Company Description
Marathon Patent Group, Inc. is a patent and patent rights acquisition and licensing company. It acquires patents and patent rights from patent holders ranging from individual inventors to fortune 500 companies. The company was founded on February 23, 2010 and is headquartered in Los Angeles, CA.
Sector: Services
Industry: Business Services
Country: United States